A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy Participants

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University First Hospital, Beijing, China

Study leads

Clinical Trials
Study Director
Hoffmann-La Roche

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated

Healthy

Abroad (travel likely)RecruitingPHASE1

Berlin, Germany

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.

Healthy Participants · Obesity

Abroad (travel likely)RecruitingPHASE1

Glendale, United States · Brooklyn, United States

A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy Subjects

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Auckland, New Zealand

A Study to Evaluate the Safety of Increasing Doses of DF5112 in Healthy Adults

Healthy Participants · Healthy Adult Females · Healthy Adult Male

Abroad (travel likely)RecruitingPHASE1

Sydney, Australia